Network model of survival signaling in large granular lymphocyte leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 42, 2008, Pages 16308-16313

  Zhang, Ranran ^a   Shah, Mithun Vinod ^a   Yang, Jun ^a   Nyland, Susan B ^a   Liu, Xin ^a   Yun, Jong K ^a   Albert, Réka ^b   Loughran Jr , Thomas P ^a,c  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Discrete dynamic model; Nuclear factor kappa B; Signal transduction network; T box expressed in T cells; T cell large granular lymphocyte leukemia

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; SPHINGOSINE KINASE 1; TRANSCRIPTION FACTOR T BET;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENZYME ACTIVATION; HUMAN; LARGE GRANULAR LYMPHOCYTE; LYMPHATIC LEUKEMIA; MOLECULAR MODEL; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; HUMANS; INTERLEUKIN-15; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; MODELS, BIOLOGICAL; NF-KAPPA B; PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED;

EID: 55849100058     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0806447105     Document Type: Article

References (38)

1. Klebanoff CA, Gattinoni L, Restifo NP (2006) CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev 211:214-224.
2. Sokol L, Loughran TP, Jr (2006) Large granular lymphocyte leukemia. Oncologist 11:263-273.
3. Epling-Burnette PK, et al. (2001) Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest 107:351-362.
4. Schade AE, Powers JJ, Wlodarski MW, Maciejewski JP (2006) Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis. Blood 107:4834-4840.
5. Epling-Burnette PK, et al. (2004) ERK couples chronic survival of NK cells to constitutively activated Ras in lymphoproliferative disease of granular lymphocytes (LDGL). Oncogene 23:9220-9229.
6. Lamy T, Liu JH, Landowski TH, Dalton WS, Loughran TP, Jr (1998) Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3+ large granular lymphocyte leukemia. Blood 92:4771-4777.
7. Krueger A, Fas SC, Baumann S, Krammer PH (2003) The role of CD95 in the regulation of peripheral T-cell apoptosis. Immunol Rev 193:58-69.
8. Shah MV, et al. (2008) Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes. Blood 112:770-781.
9. Christensen C, Thakar J, Albert R (2007) Systems-level insights into cellular regulation: Inferring, analysing, and modelling intracellular networks. IET Syst Biol 1:61-77.
10. Li S, Assmann SM, Albert R (2006) Predicting essential components of signal transduction networks: A dynamic model of guard cell abscisic acid signaling. PLoS Biol 4:e312.
11. Chaves M, Albert R, Sontag ED (2005) Robustness and fragility of Boolean models for genetic regulatory networks. J Theor Biol 235(3):431-449.
12. Wlodarski MW, et al. (2005) Pathologic clonal cytotoxic T-cell responses: Nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 106:2769-2780.
13. Zambello R, et al. (1997) Interleukin-15 triggers the proliferation and cytotoxicity of granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Blood 89:201-211.
14. Kothapalli R, et al. (2005) Constitutive production of proinflammatory cytokines RANTES, MIP-1beta and IL-18 characterizes LGL leukemia. Int J Oncol 26:529-535.
15. Heldin C-H, Westermark B (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283-1316.
16. French KJ, et al. (2003) Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res 63:5962-5969.
17. French KJ, et al. (2006) Antitumor activity of sphingosine kinase inhibitors. J Pharmacol Exp Ther 318:596-603.
18. Hoffmann A, Baltimore D (2006) Circuitry of nuclear factor κB signaling. Immunol Rev 210:171-186.
19. Pierce JW, et al. (1997) Novel Inhibitors of Cytokine-induced Iκ Bα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo. J Biol Chem 272:21096-21103.
20. Mori N, et al. (2002) Bay 11-7082 inhibits transcription factor NF-kappa B and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. Blood 100:1828-1834.
21. Loughran TP, Jr., Aprile JA, Ruscetti FW (1990) Anti-CD3 monoclonal antibody-mediated cytotoxicity occurs through an interleukin-2-independent pathway in CD3+ large granular lymphocytes. Blood 75:935-940.
22. Kothapalli R, et al. (2003) Constitutive expression of cytotoxic proteases and down-regulation of protease inhibitors in LGL leukemia. Int J Oncol 22:33-39.
23. Yang J, et al. (2008) Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia. Blood 111:1610-1616.
24. Liu K, Catalfamo M, Li Y, Henkart PA, Weng N-p (2002) IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc Natl Acad Sci USA 99:6192-6197.
25. Weng N-P, Liu K, Catalfamo M, Li YU, Henkart PA (2002) IL-15 is a growth factor and an activator of CD8 memory T cells. Ann NY Acad Sci 975:46-56.
26. Fehniger TA, et al. (2001) Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells. J Exp Med 193:219-232.
27. Hsu C, et al. (2007) Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene. Blood 109:5168-5177.
28. Mannaioni PF, Di Bello MG, Masini E (1997) Platelets and inflammation: Role of platelet-derived growth factor, adhesion molecules and histamine. Inflammation Res 46:4-18.
29. Daynes RA, Dowell T, Araneo BA (1991) Platelet-derived growth factor is a potent biologic response modifier of T cells. J Exp Med 174:1323-1333.
30. Hayden MS, West AP, Ghosh S (2006) NF-κB and the immune response. Oncogene 25:6758-6780.
31. Intlekofer AM, et al. (2005) Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol 6:1236-1244.
32. Hamann D, et al. (1997) Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med 186:1407-1418.
33. Nath N, Prasad R, Giri S, Singh AK, Singh I (2006) T-bet is essential for the progression of experimental autoimmune encephalomyelitis. Immunology 118:384-391.
34. Solomou EE, Keyvanfar K, Young NS (2006) T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood 107:3983-3991.
35. Juedes AE, Rodrigo E, Togher L, Glimcher LH, von Herrath MG (2004) T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J Exp Med 199:1153-1162.
36. Lovett-Racke AE, et al. (2004) Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity 21:719-731.
37. Albert R, et al. (2007) A novel method for signal transduction network inference from indirect experimental evidence. J Comput Bio 14:927-949.
38. Kachalo S, Zhang R, Sontag E, Albert R, DasGupta B (2008) NET-SYNTHESIS: A software for synthesis, inference and simplification of signal transduction networks. Bioinformatics 24:293-295.